// App-Quantinova.ai

2266 : Molecular and genomic characterization of SCLC

Researchers

Presenter

  • Stephen V. Liu

Principal Investigators

  • Edward S. Kim

  • Rebecca A. Feldman

  • Zoran Gatalica

  • Jeffrey Swensen

  • Hossein Borghaei

  • Alexander I. Spira

  • Gerold Bepler

  • Sandeep Reddy

  • Afshin Dowlati

Medical Centers

  • Georgetown University Lombardi Comprehensive Cancer Center, Washington, DC

  • Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC

  • Caris Life Sciences, Phoenix, AZ

  • Fox Chase Cancer Center, Philadelphia, PA

  • Virginia Cancer Specialists, Fairfax, VA

  • Karmanos Cancer Institute, Detroit, MI

  • University Hospitals Case Medical Center, Cleveland, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

  • Small cell lung cancer

  • Lung Cancer

  • Solid malignancies

Biomarkers

  • Adenomatous Polyposis Coli

  • Neurogenic locus notch homolog protein 1

  • High affinity nerve growth factor receptor

  • B-Raf proto-oncogene, serine/threonine kinase

  • Breast cancer type 2 susceptibility protein

  • Patched 1

  • Programmed death-ligand 1

  • Cyclin D1

  • Cyclin D3

  • Cyclin Dependent Kinase Inhibitor 2A

  • Ret Proto-Oncogene

  • Retinoblastoma protein

  • Epidermal growth factor receptor

  • Excision repair cross-complementation group 1

  • Fibroblast growth factor receptor 1

  • Insulin-like growth factor 1 receptor

  • Tumor protein p53

  • tumor-infiltrating lymphocytes

  • Neurofibromatosis type 1

Drug/Treatment

  • TP53

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved